Comparative Effectiveness of Intervention in Multi-level Hospitals for Acute Traumatic Brain Injury(Metric-TBI)
Launched by BEIJING TIANTAN HOSPITAL · May 23, 2024
Trial Information
Current as of February 19, 2025
Recruiting
Keywords
ClinConnect Summary
The Metric-TBI trial is studying the best ways to treat patients with acute traumatic brain injury (TBI) in different hospitals. This research aims to find out which treatment methods work best to help patients recover and improve their health outcomes. The trial is currently looking for participants, including people aged 1 to 89 who have symptoms of TBI and have been diagnosed through imaging tests like CT scans or MRIs.
To join the study, patients or their family members must give written consent, and participants will need to attend follow-up visits to track their progress. However, individuals over 90 years old, those with other serious illnesses, or who cannot provide complete information will not be included. If eligible, participants can expect to contribute to important research that could improve treatment options for TBI in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient (1 years to 89 years) presenting with clinical symptoms of traumatic brain injury
- • Traumatic brain injury verified on cranial computed tomography or magnetic resonance imaging
- • Written informed consent from patients or their next of kin according to the patient's cognitive status
- Exclusion Criteria:
- • patients ≥90 years of age
- • patients who did not accept follow-up visits or were unable to complete follow-up assessments
- • patients with incomplete information
- • patients who did not obtain written informed consent
- • patients with concomitant cancer or other serious illnesses
Trial Officials
Weiming Liu, M.D.
Principal Investigator
Beijing Tiantan Hospital
About Beijing Tiantan Hospital
Beijing Tiantan Hospital, affiliated with Capital Medical University, is a leading medical institution in China renowned for its expertise in neurology, neurosurgery, and various other specialties. As a prominent clinical trial sponsor, the hospital is committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on high-quality clinical trials, Beijing Tiantan Hospital adheres to rigorous ethical standards and regulatory requirements, fostering collaboration with academic institutions and industry partners to facilitate the development of cutting-edge therapies and interventions. Its state-of-the-art facilities and experienced research team enable the hospital to play a pivotal role in the global medical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Beijing, , China
Beijing, Beijing, China
Chengde, Hebei, China
Shijiazhuang, Hebei, China
Beijing, Beijing, China
Shijiazhuang, Hebei, China
Xingtai, Hebei, China
Shijiazhuang, Hebei, China
Baoding, Hebei, China
Tianjin, Tianjin, China
Beijing, , China
Beijing, Beijing, China
Handan, Hebei, China
Tangshan, Hebei, China
Langfang, Hebei, China
Tianjin, Tianjin, China
Beijing, Beijing, China
Beijing, Beijing, China
Beijing, Beijing, China
Beijing, Beijing, China
Beijing, Beijing, China
Beijing, Beijing, China
Beijing, Beijing, China
Beijing, Beijing, China
Beijing, Beijing, China
Beijing, Beijing, China
Beijing, Beijing, China
Baoding, Hebei, China
Baoding, Hebei, China
Baoding, Hebei, China
Baoding, Hebei, China
Baoding, Hebei, China
Baoding, Hebei, China
Cangzhou, Hebei, China
Chengde, Hebei, China
Handan, Hebei, China
Handan, Hebei, China
Handan, Hebei, China
Hengyang, Hebei, China
Langfang, Hebei, China
Langfang, Hebei, China
Langfang, Hebei, China
Langfang, Hebei, China
Shijiazhuang, Hebei, China
Shijiazhuang, Hebei, China
Shijiazhuang, Hebei, China
Shijiazhuang, Hebei, China
Shijiazhuang, Hebei, China
Shijiazhuang, Hebei, China
Tangshan, Hebei, China
Tangshan, Hebei, China
Xingtai, Hebei, China
Xingtai, Hebei, China
Xingtai, Hebei, China
Beijing, Beijing, China
Beijing, Beijing, China
Baoding, Hebei, China
Baoding, Hebei, China
Baoding, Hebei, China
Chengde, Hebei, China
Langfang, Hebei, China
Langfang, Hebei, China
Langfang, Hebei, China
Langfang, Hebei, China
Qinhuangdao, Hebei, China
Qinhuangdao, Hebei, China
Qinhuangdao, Hebei, China
Qinhuangdao, Hebei, China
Qinhuangdao, Hebei, China
Shijia Zhuang, Hebei, China
Xingtai, Hebei, China
Xingtai, Hebei, China
Xingtai, Hebei, China
Xingtai, Hebei, China
Xingtai, Hebei, China
Xingtai, Hebei, China
Tianjin, Tianjin, China
Tianjin, Tianjin, China
Tianjin, Tianjin, China
Langfang, Hebei, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0